🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effect of food, formulation, a...
Status
Completed
Location
Celerion (Site 0001)
Start Date
2023-09-20
Trial ID
NCT06619314
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
This study is a Phase 1, randomized, open label, single dose, 6 treatment, ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-02-12
Trial ID
NCT02725112
Treatments Being Tested
A multi-center, observer-masked, randomized, parallel group efficacy and sa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01452009
Treatments Being Tested
The aim of the study is to compare how different formulations of AZD0530 ar...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00771979
This study is a multicenter, open-label study of polatuzumab vedotin admini...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-10-15
Trial ID
NCT02257567
This study intends to demonstrate bioequivalence of two formulations, the e...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-07
Trial ID
NCT00449774
Treatments Being Tested
This is an open-label, single centre, repeat dose, up- titration study in h...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-10
Trial ID
NCT01332513
The purpose of the study is to investigate PK of levodopa in plasma after r...
Status
Completed
Location
Clinical Pharmacology Unit, Orion Pharma
Start Date
2017-04-19
Trial ID
NCT03140956
Treatments Being Tested
This phase 2 study will evaluate the safety, immunogenicity and optimal tim...
Status
Completed
Location
Desmond Tutu HIV Centre Cape Town
Start Date
2005-10
Trial ID
NCT00888446
Treatments Being Tested